Lucentis 0.23mg

Lucentis 0.23mg

Lucentis 0.23mg by Novartis is used by doctors as injectable which stops the retinal diseases progression, such as wet age-related macular degeneration (wet AMD), central or branch retinal vein occlusion (BRVO or CRVO) and diabetic macular edema (DME).

Lucentis injections assist in reducing the excess blood vessel growth, which is caused by retinal diseases, lowering eye pressure to assist in maintaing eyesight or possibly reversing vision loss in some patients. This product is chosen by doctors because by being an injectable it delivers the product to the exact spot to treat the eye.